Overview

A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet

Status:
Completed
Trial end date:
2018-10-12
Target enrollment:
Participant gender:
Summary
The purposes of this study are to evaluate BE between a single-dose of TAK-438ASA tablet versus a single-dose combination of TAK-438 tablet 10 milligram (mg) and aspirin enteric-coated tablet 100 mg in Japanese healthy adult men (Study 1), and to evaluate the effects of food on the pharmacokinetics of TAK-438ASA tablet in Japanese healthy adult men (Study 2).
Phase:
Phase 1
Details
Lead Sponsor:
Takeda
Treatments:
Aspirin